Results 291 to 300 of about 8,862,620 (337)

Are there ethical differences between stopping and not starting blood safety measures?

Vox Sanguinis, 2017
K. Kramer, M. Verweij, H. Zaaijer
semanticscholar   +1 more source

Pathogen Inactivation Technologies: The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk.

Hematology/Oncology Clinics of North America, 2016
D. Devine, P. Schubert
semanticscholar   +1 more source

Improving blood safety worldwide

The Lancet, 2007
openaire   +2 more sources

Safety of placental blood derivatives

The Lancet, 1994
F, Barré-Sinoussi, A, Bussel, L, Court, A, Pernod, J L, Tayot, J M, Rouzioux   +5 more
openaire   +2 more sources

Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications

Ca-A Cancer Journal for Clinicians, 2014
William W Tseng
exaly  

Blood safety and democracy

The Lancet, 2007
openaire   +2 more sources

Blood proteomics and transfusion safety

Journal of Proteomics, 2010
John R, Hess, Giuliano, Grazzini
openaire   +2 more sources

Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers

Ca-A Cancer Journal for Clinicians, 2003
Robert A Smith
exaly  

Risk of transfusion‐transmitted chikungunya infection and efficacy of blood safety implementation measures: experience from the 2009 epidemic in Songkhla Province, Thailand

Transfusion, 2016
H. Appassakij, C. Promwong, Pairaya Rujirojindakul, P. Khuntikij, K. Silpapojakul   +4 more
semanticscholar   +1 more source

Application of Nanotechnology in Cancer Therapy and Imaging

Ca-A Cancer Journal for Clinicians, 2008
Dong M Shin
exaly